This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Suzhou Smartnuclide Biopharmaceutical Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Hao Qi - Innovator in Biomedicine
Introduction
Hao Qi is a prominent inventor based in Suzhou, China. He has made significant contributions to the field of biomedicine, particularly in the development of innovative polypeptides. His work focuses on advancing medical diagnostics and treatments for serious diseases.
Latest Patents
Hao Qi holds a patent for a PD-L1-binding polypeptide and its applications. This invention is crucial in the detection and diagnosis of PD-L1 related diseases, including various forms of cancer. The patent highlights the potential of these polypeptides in improving patient outcomes through early detection and targeted therapies. He has 1 patent to his name.
Career Highlights
Hao Qi is currently employed at Suzhou Smartnuclide Biopharmaceutical Co., Ltd. His role at the company allows him to apply his expertise in biomedicine and contribute to the development of groundbreaking therapies. His work is instrumental in pushing the boundaries of medical science.
Collaborations
Hao Qi collaborates with talented professionals in his field, including colleagues Tao Xu and Yan Sun. Their combined efforts enhance the research and development capabilities of their organization, fostering innovation in biopharmaceuticals.
Conclusion
Hao Qi is a dedicated inventor whose work in biomedicine is paving the way for advancements in cancer detection and treatment. His contributions are vital to the ongoing efforts to improve healthcare outcomes for patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile